SMTL ID : 4ihb.8 (7 other biounits)

X-RAY STRUCTURE OF THE canonical C2A DOMAIN FROM HUMAN DYSFERLIN

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.04 Å

Oligo State

homo-hexamer

Ligands

40 x FMT: FORMIC ACID(Non-functional Binders)

FMT.1: 3 residues within 4Å: Chain A: G.35, V.36, K.37 Ligand excluded by PLIP FMT.2: 4 residues within 4Å: Chain A: K.38, E.56, W.57, D.58 Ligand excluded by PLIP FMT.3: 4 residues within 4Å: Chain A: K.38, F.55, E.56 Ligands: FMT.7 Ligand excluded by PLIP FMT.4: 4 residues within 4Å: Chain A: K.41, W.51, N.52, E.53 Ligand excluded by PLIP FMT.5: 3 residues within 4Å: Chain E: K.41, W.51, N.52 Ligand excluded by PLIP FMT.6: 4 residues within 4Å: Chain A: V.36, K.37, K.38 Ligands: FMT.8 Ligand excluded by PLIP FMT.7: 5 residues within 4Å: Chain A: K.38, R.39, F.55 Ligands: FMT.3, FMT.8 Ligand excluded by PLIP FMT.8: 3 residues within 4Å: Chain A: K.37 Ligands: FMT.6, FMT.7 Ligand excluded by PLIP FMT.9: 3 residues within 4Å: Chain A: V.32, H.71 Ligands: FMT.11 Ligand excluded by PLIP FMT.10: 4 residues within 4Å: Chain A: F.33, A.34, E.69 Ligands: FMT.11 Ligand excluded by PLIP FMT.11: 7 residues within 4Å: Chain A: V.32, F.33, A.34, G.35, E.69 Ligands: FMT.9, FMT.10 Ligand excluded by PLIP FMT.12: 6 residues within 4Å: Chain A: N.107, V.123 Chain E: S.101, S.103, A.104, Q.125 Ligand excluded by PLIP FMT.13: 8 residues within 4Å: Chain B: R.8, S.101, L.102, S.103, S.127, Y.128 Chain D: Y.13, E.15 Ligand excluded by PLIP FMT.14: 5 residues within 4Å: Chain B: K.38, R.39, F.55 Ligands: FMT.15, FMT.16 Ligand excluded by PLIP FMT.15: 2 residues within 4Å: Chain B: K.37 Ligands: FMT.14 Ligand excluded by PLIP FMT.16: 5 residues within 4Å: Chain B: R.39, T.40, K.41, E.53 Ligands: FMT.14 Ligand excluded by PLIP FMT.17: 5 residues within 4Å: Chain B: N.16, V.17, H.18, T.118, A.120 Ligand excluded by PLIP FMT.18: 4 residues within 4Å: Chain B: A.89, K.90, P.109 Chain C: D.65 Ligand excluded by PLIP FMT.20: 6 residues within 4Å: Chain C: S.105, V.123 Chain F: S.103, A.104, Q.125 Ligands: FMT.42 Ligand excluded by PLIP FMT.21: 5 residues within 4Å: Chain C: E.95, A.104, S.105 Chain F: S.105 Ligands: FMT.41 Ligand excluded by PLIP FMT.22: 3 residues within 4Å: Chain D: G.35, V.36, K.37 Ligand excluded by PLIP FMT.23: 4 residues within 4Å: Chain D: K.38, E.56, W.57, D.58 Ligand excluded by PLIP FMT.24: 4 residues within 4Å: Chain D: K.38, F.55, E.56 Ligands: FMT.28 Ligand excluded by PLIP FMT.25: 4 residues within 4Å: Chain D: K.41, W.51, N.52, E.53 Ligand excluded by PLIP FMT.26: 3 residues within 4Å: Chain B: K.41, W.51, N.52 Ligand excluded by PLIP FMT.27: 4 residues within 4Å: Chain D: V.36, K.37, K.38 Ligands: FMT.29 Ligand excluded by PLIP FMT.28: 5 residues within 4Å: Chain D: K.38, R.39, F.55 Ligands: FMT.24, FMT.29 Ligand excluded by PLIP FMT.29: 3 residues within 4Å: Chain D: K.37 Ligands: FMT.27, FMT.28 Ligand excluded by PLIP FMT.30: 3 residues within 4Å: Chain D: V.32, H.71 Ligands: FMT.32 Ligand excluded by PLIP FMT.31: 4 residues within 4Å: Chain D: F.33, A.34, E.69 Ligands: FMT.32 Ligand excluded by PLIP FMT.32: 7 residues within 4Å: Chain D: V.32, F.33, A.34, G.35, E.69 Ligands: FMT.30, FMT.31 Ligand excluded by PLIP FMT.33: 6 residues within 4Å: Chain B: S.101, S.103, A.104, Q.125 Chain D: N.107, V.123 Ligand excluded by PLIP FMT.34: 8 residues within 4Å: Chain A: Y.13, E.15 Chain E: R.8, S.101, L.102, S.103, S.127, Y.128 Ligand excluded by PLIP FMT.35: 5 residues within 4Å: Chain E: K.38, R.39, F.55 Ligands: FMT.36, FMT.37 Ligand excluded by PLIP FMT.36: 2 residues within 4Å: Chain E: K.37 Ligands: FMT.35 Ligand excluded by PLIP FMT.37: 5 residues within 4Å: Chain E: R.39, T.40, K.41, E.53 Ligands: FMT.35 Ligand excluded by PLIP FMT.38: 5 residues within 4Å: Chain E: N.16, V.17, H.18, T.118, A.120 Ligand excluded by PLIP FMT.39: 4 residues within 4Å: Chain E: A.89, K.90, P.109 Chain F: D.65 Ligand excluded by PLIP FMT.41: 6 residues within 4Å: Chain C: S.103, A.104, Q.125 Chain F: S.105, V.123 Ligands: FMT.21 Ligand excluded by PLIP FMT.42: 5 residues within 4Å: Chain C: S.105 Chain F: E.95, A.104, S.105 Ligands: FMT.20 Ligand excluded by PLIP

2 x CA: CALCIUM ION(Non-covalent)

CA.19: 4 residues within 4Å: Chain B: D.23, I.24, D.26, N.45 5 PLIP interactions: 4 interactions with chain B, 1 Ligand-Water interactions Metal complexes: B:D.23, B:I.24, B:D.26, B:D.26, H2O.4 CA.40: 4 residues within 4Å: Chain E: D.23, I.24, D.26, N.45 5 PLIP interactions: 4 interactions with chain E, 1 Ligand-Water interactions Metal complexes: E:D.23, E:I.24, E:D.26, E:D.26, H2O.9

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Fuson, K. et al., Alternate Splicing of Dysferlin C2A Confers Ca(2+)-Dependent and Ca(2+)-Independent Binding for Membrane Repair. Structure (2014)

Release Date

2013-12-18

Peptides

Dysferlin: ABCDEF

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
D

B
E

C
F

D
D

E
E

F
F

Dysferlin

Related Entries With Identical Sequence